Combination of an anti edb fibronectin domain antibody...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 35/00 (2006.01) A61K 51/10 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2650953

The invention relates to a combination (i) of a fusion protein, comprising an .epsilon.s2-CH4 domain part and an antibody part, specifically recognising the extra domain B of fibronectin (ED-B - fibronectin), and (ii) and an anti-EGFR-antibody and its use for treatment of cancer, in particular head and neck cancer, non-small cell lung cancer, prostate cancer, colorectal cancer, ovarian cancer, pancreatic cancer, gastric cancer, and / or breast cancer.

L'invention porte sur une combinaison (i) d'une protéine de fusion comprenant une partie de domaine .epsilon.s2-CH4 et une partie d'un anticorps reconnaissant spécifiquement l'extradomaine B de la fibronectine (ED-B - fibronectine), et (ii) un anticorps anti-EGFR, et sur ses utilisations pour le traitement de cancers, en particulier de la tête et du cou, du poumon hors petites cellules, de la prostate, de l'estomac et/ou du sein.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of an anti edb fibronectin domain antibody... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of an anti edb fibronectin domain antibody..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of an anti edb fibronectin domain antibody... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2014631

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.